Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe and Asia. The company operates through four segments: Metrics Contract Services, International, Branded Products, and Portfolio Products. It provides oral drug delivery systems; and contract pharmaceutical development, manufacturing, and analytical services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.

Dr. Andrew O. Herdman Ph.D.

Vice President of Group HR

Mr. Brenton  Walter

Financial Controller

Ms. Laura  Loftus

Associate Gen. Counsel & Company Sec.

Dr. Frank  Casty M.D.

Executive Vice President & Global Chief Medical Officer

Mr. Hemanshu N. Pandya

Senior Vice President & Head of Generic Product Division

Mr. Shawn Patrick O'Brien B.Sc

Chief Executive Officer, MD & Director

Ms. Kimberly  Parker J.D.

Executive Vice President & Gen. Counsel

Mr. Daniel  Moore

Executive Vice President of Commercial

Mr. Aaron  Gray

Chief Financial Officer

Mr. Brant  Schofield

Executive Vice President of Corporation Devel.

Ms. Erinn  Nathaniel

Director of Global HR

Ms. Lisa  Pendlebury

Vice President of Investor Relations & Communications

Mr. Stefan J. Cross

Pres of International Operations

Mr. Gerard G. Nahum M.D.

Chief Medical Officer

Arzneimittelhersteller allgemein

Mayne Pharma Group Limited

Mayne Pharma Group Limited Management-Struktur

Informationen zum Management